The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Exosomes and tumor-mediated immune suppression
Open accessAbstract
Tumor-derived exosomes (TEX) are harbingers of tumor-induced immune suppression: they carry immunosuppressive molecules and factors known to interfere with immune cell functions. By delivering suppressive cargos consisting of proteins similar to those in parent tumor cells to immune cells, TEX directly or indirectly influence the development, maturation, and antitumor activities of immune cells. TEX also deliver genomic DNA, mRNA, and microRNAs to immune cells, thereby reprogramming functions of responder cells to promote tumor progression. TEX carrying tumor-associated antigens can interfere with antitumor immunotherapies. TEX also have the potential to serve as noninvasive biomarkers of tumor progression. In the tumor microenvironment, TEX may be involved in operating numerous signaling pathways responsible for the downregulation of antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Self-citationRegulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260 · cited 1×
“Because TEX can mediate either a loss or gain of antitumor immune responses (16, 17), a controversy has evolved concerning their biological role.”
BackgroundPan, B.-T., & Johnstone, R. M. (1983) · Cell · doi:10.1016/0092-8674(83)90040-5 · Cited by 2,032
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Théry, C., & Raposo, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.128868 · Cited by 1,463
Ectosomes and exosomes: shedding the confusion between extracellular vesicles
Cocucci, E., & Meldolesi, J. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.01.004 · Cited by 1,435
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367 · cited 1×
“The data suggesting that total or individual protein levels in TEX might correlate with cancer progression or responses to therapy have led to extensive proteomic analyses of EVs isolated from tumor cell supernatants and to the identification of several thousand different molecules carried by EVs and listed in the Ves…”
BackgroundExosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A., Inanlou, M. R., Chiu, E., Buchanan, M., Hosein, A. N., Basik, M., & Wrana, J. L. (2012) · Cell · doi:10.1016/j.cell.2012.11.024 · Cited by 1,311
Hypoxic enhancement of exosome release by breast cancer cells
King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045
Kahlert, C., Melo, S. A., Protopopov, A., Tang, J., Seth, S., Koch, M., Zhang, J., Weitz, J., Chin, L., Futreal, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.532267 · Cited by 1,026
Active Wnt proteins are secreted on exosomes
Gross, J. C., Chaudhary, V., Bartscherer, K., & Boutros, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2574 · Cited by 1,024
Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.-P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40483 · Cited by 998
Exosomes in cancer: small particle, big player
Zhang, X., Yuan, X., Shi, H., Wu, L., Qian, H., & Xu, W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0181-x · Cited by 780
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Body fluid derived exosomes as a novel template for clinical diagnostics
Keller, S., Ridinger, J., Rupp, A.-K., Janssen, J. W., & Altevogt, P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-86 · Cited by 751
Induction of myeloid‐derived suppressor cells by tumor exosomes
Xiang, X., Poliakov, A., Liu, C., Liu, Y., Deng, Z., Wang, J., Cheng, Z., Shah, S. V., Wang, G., Zhang, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24249 · Cited by 598
Exosomes and their roles in immune regulation and cancer
Greening, D. W., Gopal, S. K., Xu, R., Simpson, R. J., & Chen, W. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.009 · Cited by 597
Circulating miRNAs are correlated with tumor progression in prostate cancer
Brase, J. C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., & Sültmann, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25376 · Cited by 587
Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
Clayton, A., Mitchell, J. P., Court, J., Linnane, S., Mason, M. D., & Tabi, Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7249 · Cited by 574
Kim, D., Kang, B., Kim, O. Y., Choi, D., Lee, J., Kim, S. R., Go, G., Yoon, Y. J., Kim, J. H., Jang, S. C., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20384 · Cited by 569
Wieckowski, E. U., Visus, C., Szajnik, M., Szczepanski, M. J., Storkus, W. J., & Whiteside, T. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900970 · Cited by 560
Self-citationExosomes as intercellular signalosomes and pharmacological effectors
Record, M., Subra, C., Silvente-Poirot, S., & Poirot, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.011 · Cited by 537
Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., & Tabi, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3456 · Cited by 520
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy
Ciravolo, V., Huber, V., Ghedini, G. C., Venturelli, E., Bianchi, F., Campiglio, M., Morelli, D., Villa, A., Mina, P. D., Menard, S., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22773 · Cited by 514
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
Liu, C., Yu, S., Zinn, K., Wang, J., Zhang, L., Jia, Y., Kappes, J. C., Barnes, S., Kimberly, R. P., Grizzle, W. E., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1375 · Cited by 500
Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., Watkins, S., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1010.11.3 · Cited by 497
Self-citationTumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
Szajnik, M., Czystowska, M., Szczepanski, M. J., Mandapathil, M., & Whiteside, T. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011469 · Cited by 462
Self-citationMicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Dai, R., & Ahmed, S. A. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.007 · Cited by 444
Tumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425
Szczepanski, M. J., Szajnik, M., Welsh, A., Whiteside, T. L., & Boyiadzis, M. (2011) · Haematologica · doi:10.3324/haematol.2010.039743 · Cited by 422
Self-citationTumor-Released Microvesicles as Vehicles of Immunosuppression
Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., & Rivoltini, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0520 · Cited by 409
Hoffmann, T. K., Dworacki, G., Tsukihiro, T., Meidenbauer, N., Gooding, W. E., Johnson, J. T., & Whiteside, T. L. (2002) · PubMed · Cited by 388
Self-citationWhiteside, T. L. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120265 · Cited by 388
Self-citationZhang, H.-G., & Grizzle, W. E. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.027 · Cited by 352
Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosomes
Palanisamy, V., Sharma, S., Deshpande, A., Zhou, H., Gimzewski, J., & Wong, D. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008577 · Cited by 348
Ye, S.-B., Li, Z.-L., Luo, D.-H., Huang, B.-J., Chen, Y.-S., Zhang, X.-S., Cui, J., Zeng, Y.-X., & Li, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2118 · Cited by 346
Poliakov, A., Spilman, M., Dokland, T., Amling, C. L., & Mobley, J. A. (2009) · The Prostate · doi:10.1002/pros.20860 · Cited by 324
Transfer of extracellular vesicles during immune cell‐cell interactions
Gutiérrez‐Vázquez, C., Villarroya‐Beltri, C., Mittelbrunn, M., & Sánchez‐Madrid, F. (2013) · Immunological Reviews · doi:10.1111/imr.12013 · Cited by 323
The Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells
Putz, U., Howitt, J., Doan, A., Goh, C.-P., Low, L.-H., Silke, J., & Tan, S.-S. (2012) · Science Signaling · doi:10.1126/scisignal.2003084 · Cited by 312
Abd Elmageed, Z. Y., Yang, Y., Thomas, R., Ranjan, M., Mondal, D., Moroz, K., Fang, Z., Rezk, B. M., Moparty, K., Sikka, S. C., et al. (2014) · Stem Cells · doi:10.1002/stem.1619 · Cited by 295
Stenqvist, A.-C., Nagaeva, O., Baranov, V., & Mincheva-Nilsson, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301885 · Cited by 292
Lázaro‐Ibáñez, E., Sanz‐Garcia, A., Visakorpi, T., Escobedo‐Lucea, C., Siljander, P., Ayuso‐Sacido, Á., & Yliperttula, M. (2014) · The Prostate · doi:10.1002/pros.22853 · Cited by 284
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
Filipazzi, P., Bürdek, M., Villa, A., Rivoltini, L., & Huber, V. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.005 · Cited by 283
Taylor, D. D., Gerçel-Taylor, Ç., Lyons, K. S., Stanson, J., & Whiteside, T. L. (2003) · PubMed · Cited by 281
Self-citationSchuler, P. J., Saze, Z., Hong, C.-S., Muller, L., Gillespie, D. G., Cheng, D., Harasymczuk, M., Mandapathil, M., Lang, S., Jackson, E. K., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12354 · Cited by 277
Self-citationCurtale, G., Citarella, F., Carissimi, C., Goldoni, M., Carucci, N., Fulci, V., Franceschini, D., Meloni, F., Barnaba, V., & Macino, G. (2010) · Blood · doi:10.1182/blood-2009-06-225987 · Cited by 263
Association of citrullinated proteins with synovial exosomes
Skriner, K., Adolph, K., Jungblut, P. R., & Burmester, G. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22276 · Cited by 259
RNA Trafficking by Acute Myelogenous Leukemia Exosomes
Huan, J., Hornick, N. I., Shurtleff, M. J., Skinner, A. M., Goloviznina, N. A., Roberts, C. T., & Kurre, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2184 · Cited by 259
Bretz, N. P., Ridinger, J., Rupp, A.-K., Rimbach, K., Keller, S., Rupp, C., Marmé, F., Umansky, L., Umansky, V., Eigenbrod, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512806 · Cited by 245
Formation and role of exosomes in cancer
Brinton, L. T., Sloane, H. S., Kester, M., & Kelly, K. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1764-3 · Cited by 244
Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
Hong, C.-S., Muller, L., Whiteside, T. L., & Boyiadzis, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00160 · Cited by 228
Self-citationContribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells
Liu, Y., Xiang, X., Zhuang, X., Zhang, S., Liu, C., Cheng, Z., Michalek, S., Grizzle, W., & Zhang, H.-G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090777 · Cited by 218
Hee Kim, S., Bianco, N., Menon, R., Lechman, E. R., Shufesky, W. J., Morelli, A. E., & Robbins, P. D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.015 · Cited by 217
Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
Mrizak, D., Martin, N., Barjon, C., Jimenez-Pailhes, A.-S., Mustapha, R., Niki, T., Guigay, J., Pancré, V., de Launoit, Y., Busson, P., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju363 · Cited by 211
Tumor-cell-derived microvesicles as carriers of molecular information in cancer
Martins, V. R., Dias, M. S., & Hainaut, P. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b7c81 · Cited by 211
Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia
Hong, C. S., Muller, L., Boyiadzis, M., & Whiteside, T. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103310 · Cited by 196
Self-citationImproved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice
Gu, X., Erb, U., Büchler, M. W., & Zöller, M. (2015) · International Journal of Cancer · doi:10.1002/ijc.29100 · Cited by 185
Ectosomes as modulators of inflammation and immunity
Sadallah, S., Eken, C., & Schifferli, J. A. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04271.x · Cited by 171
Taylor, D. D., & Gercel-Taylor, C. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00142 · Cited by 158
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Battke, C., Ruiss, R., WELSCH, U. N., Wimberger, P., Lang, S., Jochum, S., & Zeidler, R. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0979-5 · Cited by 155
Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function
Dunand-Sauthier, I., Santiago‐Raber, M., Capponi, L., Vejnar, C. E., Schaad, O., Irla, M., Seguín-Estévez, Q., Descombes, P., Zdobnov, E. M., Acha‐Orbea, H., et al. (2011) · Blood · doi:10.1182/blood-2010-09-308064 · Cited by 150
Mincheva‐Nilsson, L., & Baranov, V. I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.010 · Cited by 146
The potential of tumor-derived exosomes for noninvasive cancer monitoring
Whiteside, T. L. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1071666 · Cited by 143
Self-citationTumor-derived exosomes in oncogenic reprogramming and cancer progression
Saleem, S. N., & Abdel‐Mageed, A. B. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1710-4 · Cited by 140
Exosomes and communication between tumours and the immune system: are all exosomes equal?
Bobrie, A., & Théry, C. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120245 · Cited by 135
Wieckowski, E. U., & Whiteside, T. L. (2006) · Immunologic Research · doi:10.1385/ir:36:1:247 · Cited by 130
Self-citationIsolation of prostate cancer-related exosomes.
Mizutani, K., Terazawa, R., Kameyama, K., Kato, T., Horie, K., Tsuchiya, T., Seike, K., Ehara, H., Fujita, Y., Kawakami, K., et al. (2014) · PubMed · Cited by 125
Yang, C., Kim, S.-H., Bianco, N. R., & Robbins, P. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022517 · Cited by 121
Müller, L., Muller-Haegele, S., Mitsuhashi, M., Gooding, W. E., Okada, H., & Whiteside, T. L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008347 · Cited by 117
Self-citationSchuler, P. J., Schilling, B., Harasymczuk, M., Hoffmann, T. K., Johnson, J. T., Lang, S., & Whiteside, T. L. (2012) · European Journal of Immunology · doi:10.1002/eji.201142347 · Cited by 114
Self-citationRegulatory T Cell-Derived Exosomes: Possible Therapeutic and Diagnostic Tools in Transplantation
Agarwal, A., Fanelli, G., Letizia, M., Tung, S. L., Boardman, D. A., Lechler, R. I., Lombardi, G., & Smyth, L. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00555 · Cited by 107
Bergmann, C., Strauss, L., Wieckowski, E. U., Czystowska, M., Albers, A. E., Wang, Y., Zeidler, R., Lang, S., & Whiteside, T. L. (2008) · Head & Neck · doi:10.1002/hed.20968 · Cited by 102
Self-citationMicroRNAs: Key Components of Immune Regulation
Gracias, D. T., & Katsikis, P. D. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_2 · Cited by 92
Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
Whiteside, T. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00107 · Cited by 87
Self-citationImmunoregulatory activity of adenosine and its role in human cancer progression
Muller-Haegele, S., Müller, L., & Whiteside, T. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.915739 · Cited by 85
Self-citationYu, L., Yang, F., Jiang, L., Chen, Y., Wang, K., Xu, F., Wei, Y., Cao, X., Wang, J., & Cai, Z. (2013) · European Journal of Immunology · doi:10.1002/eji.201243295 · Cited by 82
Information transfer by exosomes: A new frontier in hematologic malignancies
Boyiadzis, M., & Whiteside, T. L. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.01.004 · Cited by 79
Self-citationmiR-21 is a negative modulator of T-cell activation
Carissimi, C., Carucci, N., Colombo, T., Piconese, S., Azzalin, G., Cipolletta, E., Citarella, F., Barnaba, V., Macino, G., & Fulci, V. (2014) · Biochimie · doi:10.1016/j.biochi.2014.09.021 · Cited by 78
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
Czystowska, M., Han, J., Szczepański, M. J., Szajnik, M. E., Quadrini, K. J., Brandwein, H. J., Hadden, J. W., Signorelli, K. L., & Whiteside, T. L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2008.197 · Cited by 76
Self-citationNovel insights into exosome-induced, tumor-associated inflammation and immunomodulation
Altevogt, P., Bretz, N. P., Ridinger, J., Utikal, J. S., & Umansky, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.008 · Cited by 76
Molecular Pathways: Tumor-Derived Microvesicles and Their Interactions with Immune CellsIn Vivo
Pucci, F., & Pittet, M. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0962 · Cited by 71
MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5
Li, W., Kong, L., Li, J., Guo, Z., Xue, Q., Yang, T., Meng, Y., Jin, B., Wen, W., & Yang, A. (2013) · International Immunology · doi:10.1093/intimm/dxt065 · Cited by 63
de Amorim, M. G., Fernandes, G. R., Oliveira, P., Martins‐de‐Souza, D., Dias‐Neto, E., & Nunes, D. N. (2014) · PROTEOMICS · doi:10.1002/pmic.201300485 · Cited by 55
Kim, J., Tsukishiro, T., Johnson, J. T., & Whiteside, T. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0309 · Cited by 44
Self-citationExosomes in immunity and cancer—Friends or foes?
Gabrielsson, S., & Scheynius, A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.007 · Cited by 14
Immune biomarkers: how well do they serve prognosis in human cancers?
Baxevanis, C. N., Anastasopoulou, E. A., Voutsas, I. F., Papamichail, M., & Perez, S. A. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.965684 · Cited by 9
Cited by
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Engineering exosomes as refined biological nanoplatforms for drug delivery
Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.12 · Cited by 1,163
Willms, E., Cabañas, C., Mäger, I., Wood, M. J. A., & Vader, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00738 · Cited by 981
Metadata
- Authors
- Whiteside, T. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-02-29
- Volume
- 126
- Issue
- 4
- Pages
- 1216-1223
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2292821496
- Cited by
- 569
- References
- 96
- FWCI
- 21.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.